To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:6 Issue:4 Number:35 ISSN#:2564-2537
ACE Report #9335
Ace Report Cover Metabolic Disorders

The effect of eldecalcitol on balence and strength in women with osteoporosis

How to Cite

OrthoEvidence. The effect of eldecalcitol on balence and strength in women with osteoporosis. ACE Report. 2017;6(4):35. Available from:

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Eldecalcitol improves muscle strength and dynamic balance in postmenopausal women with osteoporosis: an open-label randomized controlled study

J Bone Miner Metab. 2016 Sep;34(5):547-54

Contributing Authors:
K Saito N Miyakoshi T Matsunaga M Hongo Y Kasukawa Y Shimada

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


50 women with osteoporosis were randomized to weekly alendronate plus daily eldecalcitol, or weekly alendronate alone. The purpose of this study was to assess muscle strength and balance after 6 months of treatment in both groups. The within-group evaluation noted significant changes in the alendronate plus eldecalcitol group from baseline to 6 months in iliopsoas strength, back extensor strength,...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.